Immune Design Corp. (IMDZ)


Stock Price Forecast

April 1, 2019


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Immune Design Corp. chart...

About the Company

Develops therapeutic vaccines for the treatment of infectious and malignant diseases

Please visit http://www.immunedesign.com for more information about the company.

Sector

Health Technology

Industry

Biotechnology

Employees

50

Exchange

NASDAQ

Website

http://www.immunedesign.com

$2M

Total Revenue

50

Employees

$281M

Market Capitalization

-5.13

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $IMDZ News

How Digital Signage Can Improve Communication—And Ease The Burden On HR

18h ago, source:

Using digital signage as a communication technology can significantly reduce the work required for employee training and ...

Here are some recent breakthroughs by women-led life sciences companies in the Bay Area

4d ago, source:

PitchBook estimates there are around 280 women-led life sciences companies in the Greater Bay Area, a small percentage of the ...

8-hour time-restricted eating linked to a 91% higher risk of cardiovascular death

19h ago, source: Medical News Today

Researchers say a 16:8 intermittent fasting plan that limits calorie intake to an 8-hour window during the day might actually ...

Living drugs that reprogram patients’ immune cells show early promise against hard-to-treat brain tumors

5d ago, source: CNN on MSN

On average, patients live about 14 months after diagnosis. Now, an experimental therapy that reprograms a person’s own immune ...

2 Stocks That Have More Than Tripled This Year: Are They Buys?

on MSN ago, source:

Finding stocks that can triple in two years is hard enough. Finding those that can do so in a mere two months is that much ...

Buy Rating for AC Immune SA on Promising Alzheimer’s Vaccine Trial Design and Potential Accelerated Approval

3d ago, source:

AC Immune SA (ACIU – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Andrew Fein ...

5 Things CEOs Really Care About in 2024

on MSN ago, source:

In 2024, talent leaders and workforce strategists should tune into what CEOs care about, as these notions will signal where ...

At-Home Medical Tests: Are They Right for You?

7d ago, source: WebMD

The bottom line: At-home tests can be a convenient and useful step in the process of getting a confirmed medical diagnosis.

Protein design pioneer David Baker on why sharing code is key to building biotech startups

on MSN ago, source:

AI2 Incubator's Jenny Cronin (left), interviews David Baker, director of the University of Washington's Institute for Protein ...

Weapons: Unjammable Wire Controlled UAVs

2h ago, source: StrategyPage

The wire guidance gave the crew of the submarine firing the torpedo more control over the torpedo and could use its sonar or periscope sightings to change the direction of the wire guided torpedo.

Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort

14d ago, source:

Positive data following completion of second cohort of Phase 1 trial of Decoy 20 leads independent Safety Review Committee to recommend ...

AI at Princeton: Pushing limits, accelerating discovery and serving humanity

12h ago, source: Princeton University

At Princeton, interdisciplinary collaborations of researchers are using artificial intelligence to accelerate discovery ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...